GNTA.US Genenta Science SpA ADR

Industrials Biotechnology USA Stocks
0.9850 USD
Close of Nov 14, 2026
0.5500 2.58
Market cap
USD 47.5M
P/E
-
P/B
1.29x
ROE
-49.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is GNTA.US undervalued?

Graham number

The Graham number of Genenta Science SpA ADR cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genenta Science SpA ADR fundamental analysis

No fundamental analysis for Genenta Science SpA ADR yet.

Genenta Science SpA ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genenta Science SpA ADR

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Full company profile